Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) FCF Margin (2024)

Historic FCF Margin for Zentalis Pharmaceuticals (ZNTL) over the last 1 years, with Q4 2024 value amounting to 147.78%.

  • Zentalis Pharmaceuticals' FCF Margin changed N/A to 147.78% in Q4 2024 from the same period last year, while for Sep 2025 it was 498.82%, marking a year-over-year decrease of 743900.0%. This contributed to the annual value of 253.74% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Zentalis Pharmaceuticals reported FCF Margin of 147.78% as of Q4 2024.
  • In the past 5 years, Zentalis Pharmaceuticals' FCF Margin ranged from a high of 128.24% in Q1 2024 and a low of 147.78% during Q4 2024